R&D
 

STEMCIS is exploring forward-looking approaches for the treatment of diseases through the use of adipose tissue and its derivatives. Osteoarthritis, urinary incontinence and erectile dysfunction are currently of particular interest to the company.

STEMCIS conducts numerous preclinical and clinical projects, in collaboration with international centres of excellence. These projects concern both the development of new products and the search for new therapeutic indications for existing products.

 

  • 2018 - Mobility

    Positive results for the veterinary study on osteoarthritis treatment in dogs with Adipose Purified Microlobules (APM): significant improvement of the pain (47%) and lameness (73%) six months after treatment.

     

  • 2017 - Privacy

    Experimental study in partnership with Urosphère (Toulouse – France) to assess the efficacy of Adipose Tissue Purified Cells (ATPC) in a rat model of erectile dysfunction

    On-going study

     

  • 2017 - Mobility

    Multi-centre randomized clinical trial in Barcelona (Spain) comparing the efficacy and safety of Adipose Purified Microlobules (APM) and Hyaluronic Acid in symptomatic knee osteoarthritis

    On-going study

         

  • 2016 / 2017 - Privacy

    Clinical cases in Australia, carried out by a gynaecologist partner of STEMCIS, assessing the clinical potential of Adipose Purified Microlobules (APM), as an innovative treatment for stress urinary incontinence in women

     

  • 2016 - Mobility

    Veterinary study with ONIRIS veterinary school of Nantes (France) evaluating the potential of Adipose Purified Microlobules (APM) as a new treatment for osteoarthritis in dogs

     

  • 2013 - Mobility

    Experimental study on a rat model of knee osteoarthritis treated with adipose cells

          

  • 2012 - Privacy

    In vitro study on the effects of adipose progenitor’s cells on ischemic pathologies including erectile dysfunction